Condition
Exacerbation
Total Trials
4
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Unknown3
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04260282Unknown
Microbiome and Exacerbations in Neutrophilic Asthma
NCT03177889Not ApplicableUnknown
Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis
NCT00446667Phase 1Withdrawn
A Pilot Safety Study of Inhaled Dry Powder Mannitol in Acute Exacerbations of COPD
NCT01232140Not ApplicableUnknown
CRP-guided Antibiotic Treatment in COPD Exacerbations Admitted to the Hospital
Showing all 4 trials